156 related articles for article (PubMed ID: 7042002)
1. Characteristics of bone marrow fibroblast colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders.
Castro-Malaspina H; Gay RE; Jhanwar SC; Hamilton JA; Chiarieri DR; Meyers PA; Gay S; Moore MA
Blood; 1982 May; 59(5):1046-54. PubMed ID: 7042002
[TBL] [Abstract][Full Text] [Related]
2. Properties of myelofibrosis-derived fibroblasts.
Castro-Malaspina H; Jhanwar SC
Prog Clin Biol Res; 1984; 154():307-22. PubMed ID: 6382300
[TBL] [Abstract][Full Text] [Related]
3. Stromal cell progeny of murine bone marrow fibroblast colony-forming units are clonal endothelial-like cells that express collagen IV and laminin.
Perkins S; Fleischman RA
Blood; 1990 Feb; 75(3):620-5. PubMed ID: 2404524
[TBL] [Abstract][Full Text] [Related]
4. Human bone marrow fibroblast colony-forming units (CFU-F).
Castro-Malaspina H; Ebell W; Wang S
Prog Clin Biol Res; 1984; 154():209-36. PubMed ID: 6382294
[TBL] [Abstract][Full Text] [Related]
5. Granulopoietic effects of human bone marrow fibroblastic cells and abnormalities in the "granulopoietic microenvironment".
Greenberg BR; Wilson FZ; Woo L
Blood; 1981 Sep; 58(3):557-64. PubMed ID: 6942847
[TBL] [Abstract][Full Text] [Related]
6. [Clonogenic cultivation of bone marrow fibroblast precursors in human myeloproliferative diseases].
Kolosova LIu; Vladimirskaia EB; Kovaleva LG
Eksp Onkol; 1988; 10(2):46-8. PubMed ID: 3292215
[TBL] [Abstract][Full Text] [Related]
7. Granulocytic and stromal progenitors in the bone marrow of patients with primary myelofibrosis.
Hotta T; Utsumi M; Katoh T; Maeda H; Yamao H; Yamada H
Scand J Haematol; 1985 Mar; 34(3):251-5. PubMed ID: 3992191
[TBL] [Abstract][Full Text] [Related]
8. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
9. Megakaryocyte progenitors in the bone marrow and peripheral blood of patients with myeloproliferative diseases.
Grossi A; Vannucchi AM; Rafanelli D; Vannucchi L; Ferrini PR
Am J Hematol; 1987 Aug; 25(4):371-6. PubMed ID: 3497577
[TBL] [Abstract][Full Text] [Related]
10. Numbers of colony-forming progenitors in patients with systemic mastocytosis: potential diagnostic implications and comparison with myeloproliferative disorders.
Jordan JH; Jäger E; Sperr WR; Schwarzinger I; Födinger M; Fritsche-Polanz R; Ohler L; Geissler K; Valent P
Eur J Clin Invest; 2003 Jul; 33(7):611-8. PubMed ID: 12814399
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of in vitro growth pattern of megakaryocyte progenitors (CFU-M) in myeloproliferative disorders.
Hamaguchi H; Takano N; Sakamaki H; Enokihara H; Saito K; Furusawa S; Shishido H
Eur J Haematol; 1988 Aug; 41(2):163-9. PubMed ID: 3410010
[TBL] [Abstract][Full Text] [Related]
12. Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders: correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism.
Jensen MK; Riisbro R; Holten-Andersen MN; Brown Pde N; Junker P; Brünner N; Hasselbalch HC
Eur J Haematol; 2003 Oct; 71(4):276-82. PubMed ID: 12950237
[TBL] [Abstract][Full Text] [Related]
13. Dual role of fibronectin in hematopoietic differentiation.
Weinstein R; Riordan MA; Wenc K; Kreczko S; Zhou M; Dainiak N
Blood; 1989 Jan; 73(1):111-6. PubMed ID: 2910353
[TBL] [Abstract][Full Text] [Related]
14. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders.
Hibbin JA; Njoku OS; Matutes E; Lewis SM; Goldman JM
Br J Haematol; 1984 Jul; 57(3):495-503. PubMed ID: 6743569
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic evidence for a clonal disorder involving CFU-GEMM, BFU-E and CFU-C in patients with myeloproliferative disorders.
Sugiyama H; Ichiba S; Okuno Y; Takahashi T; Imura H; Nakamura K; Iho S; Hoshino T; Okada T; Furukawa H
Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1022-32. PubMed ID: 2588952
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF.
Li Y; Hetet G; Maurer AM; Chait Y; Dhermy D; Briere J
Br J Haematol; 1994 Jul; 87(3):471-6. PubMed ID: 7993786
[TBL] [Abstract][Full Text] [Related]
17. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
[TBL] [Abstract][Full Text] [Related]
18. Fibroblastoid colony-forming cells in myeloproliferative disorders.
Bianchi Scarrà GL; Barresi R; Ajmar F; Garrè C; Ravazzolo R; Sessarego M
Acta Haematol; 1983; 70(6):349-56. PubMed ID: 6417958
[TBL] [Abstract][Full Text] [Related]
19. Studies in feline long-term marrow culture: hematopoiesis on normal and feline leukemia virus infected stromal cells.
Linenberger ML; Abkowitz JL
Blood; 1992 Aug; 80(3):651-62. PubMed ID: 1322201
[TBL] [Abstract][Full Text] [Related]
20. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
